Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.
Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.
A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.
A JGH nursing initiative to help cancer outpatients manage their symptoms more effectively has won an award from the Order of Nurses of Quebec.
Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
The Segal Cancer Centre at the JGH has responded to COVID-19 with compassion and innovation by enabling patients can consult with oncologists by video as an alternative to face-to-face meetings.
If a parent has cancer, are children better protected if they’re shielded from the truth? No, say the books in a three-volume series that Hope & Cope has published to explain how to broach the subject with a combination of frankness and compassion.
Several types of fatal pediatric brain tumours originate during early brain development, Dr. Claudia Kleinman, of the Lady Davis Institute, and her collaborators have discovered. The genetic event that triggers the disease probably occurs in prenatal cellular development.
Individuals with cancer need to be perceived primarily as people, and not as cases or a collection of symptoms. That’s the focus of a research paper whose JGH co-authors have been honoured with a Best Publication award by the Canadian Association of Nurses in Oncology.
Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.